NMT.ch main shareholder is Roche, next NMT of Scotland.

URL for the full piece which Rayrac quotes from:



"NMT

Shares in NMT, the Livingston retractable syringe company had an abysmal 2002. The company was floundering, unable to sell its product and plagued by manufacturing problems.

Its shares now stand at a mere 1p. Yet the company could have collapsed totally had Swiss giant Roche not ridden to its rescue with a contract to supply millions of its syringes.

NMT is still loss-making and needs to sign at least one more long-term contract in the next few months if it is to prosper.

But it still has significant cash reserves and the credibility it will receive from signing the deal with Roche will advance its attempts to start playing with the big boys of the pharmaceutical industry.

Two more contracts would transform it from a basket case to a bright new hope. One for the more adventurous armchair investor. "

G.